Page last updated: 2024-12-05

2,2,4,4,6,8,8-heptamethylnonane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

2,2,4,4,6,8,8-heptamethylnonane: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

2,2,4,4,6,8,8-heptamethylnonane : A branched alkane that is nonane carrying seven methyl substituents at positions 2, 2, 4, 4, 6, 8 and 8. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID20414
CHEMBL ID3561882
CHEBI ID131383
MeSH IDM0164659

Synonyms (36)

Synonym
nonane, 2,2,4,4,6,8,8-heptamethyl-
2,2,4,4,6,8,8-heptamethylnonane
inchi=1/c16h34/c1-13(10-14(2,3)4)11-16(8,9)12-15(5,6)7/h13h,10-12h2,1-9h
nsc-77129
nsc77129
nonane,2,4,4,6,8,8-heptamethyl-
2,4,4,6,8,8-heptamethylnonane
4390-04-9
2,2,4,4,6,8,8-heptamethylnonane, 98%
H0365
CHEBI:131383
isocetane
8lp0677305 ,
unii-8lp0677305
ec 224-506-8
einecs 224-506-8
nsc 77129
FT-0609096
AKOS015912716
VCLJODPNBNEBKW-UHFFFAOYSA-N
dtxsid7052101 ,
NCGC00357049-01
cas-4390-04-9
tox21_303743
dtxcid5030668
CHEMBL3561882
(+/-)-2,2,4,4,6,8,8-heptamethylnonane
mfcd00008856
J125.176G ,
cyprane
AS-60782
CS-0204778
Q754394
D97846
2,2,4,4,6,8,8-heptamethyl-nonane
2,2,4,4,6,8,8,-heptamethylnonane

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" Their bioavailability is limited by a low aqueous solubility, which causes specific adaptations in degrading bacteria."( Degradation of anthracene and pyrene supplied by microcrystals and non-aqueous-phase liquids.
Kaestner, M; Mutnuri, S; Vasudevan, N, 2005
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
alkaneAn acyclic branched or unbranched hydrocarbon having the general formula CnH2n+2, and therefore consisting entirely of hydrogen atoms and saturated carbon atoms.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
retinoid X nuclear receptor alphaHomo sapiens (human)Potency2.06510.000817.505159.3239AID1159527
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (10.00)18.7374
1990's1 (10.00)18.2507
2000's7 (70.00)29.6817
2010's1 (10.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (10.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (10.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]